Catalyst Wire Dossier Catalyst Wire Dossier

Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution

· Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution, covering 2013-07-18 to 2013-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]

See pricing